MarzelliMJ, MazaikaPK, Barnea-GoralyN, HersheyT, TsalikianE, TamborlaneW, MaurasN, WhiteNH, BuckinghamB, BeckRW, RuedyKJ, KollmanC, ChengP, ReissAL, Diabetes Research in Children Network (DirecNet). Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes, 2014; 63: 343–53.
2.
MaurasN, MazaikaP, BuckinghamB, WeinzimerS, WhiteNH, TsalikianE, HersheyT, CatoA, ChengP, KollmanC, BeckRW, RuedyK, AyeT, FoxL, ArbelaezAM, WilsonD, TanseyM, TamborlaneW, PengD, MarzelliM, WinerKK, ReissAL, Diabetes Research in Children Network (DirecNet). Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes, 2015; 64: 1770–79.
3.
DovčK, BratinaN, BattelinoT. A new horizon for glucose monitoring. Horm Res Paediatr, 2015; 8: 149–56.
4.
NewJP, AjjanR, PfeifferAF, FreckmannG. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med, 2015; 32: 609–17.
5.
BattelinoT, CongetI, OlsenB, Schütz-FuhrmannI, HommelE, HoogmaR, SchierlohU, SulliN, BolinderJ, SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia, 2012; 55: 3155–62.
6.
RivelineJP, SchaepelynckP, ChaillousL, RenardE, Sola-GazagnesA, PenfornisA, Tubiana-RufiN, SulmontV, CatargiB, LukasC, RadermeckerRP, ThivoletC, MoreauF, BenhamouPY, GuerciB, LeguerrierAM, MillotL, SachonC, CharpentierG, HanaireH, EVADIAC Sensor Study Group. Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care, 2012; 35: 965–71.
7.
DeSalvoDJ, MaahsDM, MesserL, WadwaRP, PayneS, LyTT, BuckinghamBA. Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes. Diabetes Care, 2015; pii: dc151267.
8.
OkadaK, HibiK, GohbaraM, et al.Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes. Cardiovasc Diabetol, 2015; 14: 111.
9.
KurodaM, ShinkeT, SakaguchiK, OtakeH, TakayaT, HirotaY, SugiyamaD, NakagawaM, HarikiH, InoueT, OsueT, TaniguchiY, IwasakiM, NishioR, KinutaniH, KonishiA, HiranumaN, TakahashiH, TerashitaD, HirataK. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study. JACC Cardiovasc Interv, 2015; 8: 800–11.
10.
GohbaraM, IwahashiN, KataokaS, HayakawaY, SakamakiK, AkiyamaE, MaejimaN, TsukaharaK, HibiK, KosugeM, EbinaT, UmemuraS, KimuraK. Glycemic variability determined by continuous glucose monitoring system predicts left ventricular remodeling in patients with a first st-segment elevation myocardial infarction. Circ J, 2015; 79: 1092–99.
11.
KataokaS, GohbaraM, IwahashiN, SakamakiK, NakachiT, AkiyamaE, MaejimaN, TsukaharaK, HibiK, KosugeM, EbinaT, UmemuraS, KimuraK. Glycemic variability on continuous glucose monitoring system predicts rapid progression of non-culprit lesions in patients with acute coronary syndrome. Circ J, 2015 [Epub ahead of print]; DOI 10.1253/circj.CJ-14-1226.
12.
SungJF, KogutEA, LeeHC, MannanJL, NavabiK, TaslimiMM, El-SayedYY. Correlation of continuous glucose monitoring profiles with pregnancy outcomes in nondiabetic women. Am J Perinatol, 2015; 32: 461–68.
13.
LawGR, EllisonGT, SecherAL, DammP, MathiesenER, TempleR, MurphyHR, ScottEM. Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care, 2015; 38: 1319–25.
14.
CyprykK, BartyzelL, Zurawska-KlisM, MlynarskiW, SzadkowskaA, WilczynskiJ, NowakowskaD, WozniakLA, FendlerW. Continuous glucose monitoring in type 1diabetes pregnancy shows that fetal heart rate correlates with maternal glycemia. Diabetes Technol Ther, 2015; 17: 619–24.
15.
BattelinoT, LiabatS, VeezeHJ, CastañedaJ, ArrietaA, CohenO. Routine use of continuous glucose monitoring in 10,501 people with diabetes mellitus. Diabet Med, 2015 [Epub ahead of print] DOI 10.1111/dme.12825.
16.
AgrawalP, ZhongA, WelshJB, ShahR, KaufmanFR. Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther, 2015; 17: 316–19.
17.
BratinaN, ShalitinS, PhillipM, BattelinoT. Type 1 diabetes in the young: Organization of two national centers in Israel and Slovenia. Zdrav Var, 2015; 54: 139–45.
18.
KropffJ, BruttomessoD, DollW, FarretA, GalassoS, LuijfYM, MaderJK, PlaceJ, BoscariF, PieberTR, RenardE, DeVriesJH. Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions. Diabetes Obes Metab, 2015; 17: 343–49.
19.
MatulevicieneV, JosephJI, AndelinM, HirschIB, AttvallS, PivodicA, DahlqvistS, KlonoffD, HaraldssonB, LindM. A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther, 2014; 16: 759–67.
20.
BaileyT, BodeBW, ChristiansenMP, KlaffLJ, AlvaS. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther, 2015 [Epub ahead of print]; DOI 10.1089/dia.2014.0378.
21.
WangX, IoacaraS, DeHennisA. Long-term home study on nocturnal hypoglycemic alarms using a new fully implantable continuous glucose monitoring system in type 1 diabetes. Diabetes Technol Ther, 2015 [Epub ahead of print]; DOI 10.1089/dia.2014.0375.
22.
MortellaroM, DeHennisA. Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes. Biosens Bioelectron, 2014; 61: 227–31.
23.
YeohE, ChoudharyP, NwokoloM, AyisS, AmielSA. Interventions that restore awareness of hypoglycemia in adults with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care, 2015; 38: 1592–609.
24.
ChoudharyP, RickelsMR, SeniorPA, VantyghemMC, MaffiP, KayTW, KeymeulenB, InagakiN, SaudekF, LehmannR, HeringBJ. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care, 2015; 38: 1016–29.
25.
TanseyM, BeckR, RuedyK, TamborlaneW, ChengP, KollmanC, FoxL, WeinzimerS, MaurasN, WhiteN, TsalikianE, for the Diabetes Research in Children Network (DirecNet). Persistently high glucose levels in young children with type 1 diabetes. Pediatr Diabetes, 2014 [Epub ahead of print]; DOI 10.1111/pedi.12248.
26.
HommelE, OlsenB, BattelinoT, CongetI, Schütz-FuhrmannI, HoogmaR, SchierlohU, SulliN, GoughH, CastañedaJ, de PortuS, BolinderJ. SWITCH Study Group. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol, 2014; 51: 845–51.
27.
MetzgerM, LederhendlerL, CorcosA. Blinded continuous glucose monitoring during Yom Kippur fasting in patients with type 1 diabetes on continuous subcutaneous insulin infusion therapy. Diabetes Care, 2015; 38: e34–35.
28.
KaplanW, AfandiB. Blood glucose fluctuation during Ramadan fasting in adolescents with type 1 diabetes: findings of continuous glucose monitoring. Diabetes Care, 2015; pii: dc151108.
29.
GomezAM, GomezC, AschnerP, VelozaA, MuñozO, RubioC, VallejoS. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. J Diabetes Sci Technol, 2015; 9: 619–24.
30.
SengokuY, NakamuraK, OgataH, NabekuraY, NagasakaS, TokuyamaK. Continuous glucose monitoring during a 100-km race: a case study in an elite ultramarathon runner. Int J Sports Physiol Perform, 2015; 10: 124–27.
31.
JinSM, KimTH, OhS, BaekJ, JoungJY, ParkSM, ChoYY, SohnSY, HurKY, LeeMS, LeeMK, KimJH. Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring. Diabet Med, 2015; 32: 274–79.
